CPRX - Catalyst Pharmaceuticals Q1 2024 Earnings Preview
2024-05-07 17:20:35 ET
More on Catalyst Pharmaceuticals
- Catalyst Pharmaceuticals: Revenue Growth Lagging Expense Growth (Rating Downgrade)
- Catalyst Pharmaceuticals, Inc. (CPRX) Q4 2023 Earnings Call Transcript
- Citi starts Catalyst at buy, cites rare disease drug portfolio
- Catalyst announces US launch of Duchenne drug Agamree
- Seeking Alpha’s Quant Rating on Catalyst Pharmaceuticals